van der Meche FGA , Schmitz PIM, and the Dutch Guillain-Barré Study Group: A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome . N Engl J Med1992;326:1123-1129.
2.
Vallee L., Dulac O., Nuyts JP, et al: Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children. Neuropediatrics1993;24:235-236.
3.
Constantopoulos A., Langona E.: Intravenous immune globulin in children with Guillain-Barré syndrome. Neuropediatrics1994 ; 25:165.
4.
Homeff G., Huppertz HI, Muller K., et al: Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome. Eur J Pediatr1993 ;152:810-812.
5.
Arakawa Y., Yoshimura M., Kobayashi K., et al: The use of intravenous immunoglobulin in Miller Fisher syndrome . Brain Dev1993; 15:231-233.
6.
Al-Qudah A.: Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood . J Child Neurol1994;9:178-180.
7.
Korinthenberg R., Schulte Monting J.: Natural history and treatment effects in Guillain-Barré syndrome: A multicentre study. Arch Dis Child1996;74:281-287.
8.
Shahar E., Murphy EG, Roifman CM: Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome. Pediatr1990 ;116:141-144.
9.
Shahar EM, Chiam M., Roifman CM, et al: High dose intravenous serum gamma globulins are effective in severe pediatric Guillain-Barré syndrome: A Prospective follow-up study of 23 cases, abstract. Ann Neurol1994;36:503.
10.
Gurses N., Uysal S., Cetinkaya F., et al: Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Scand J Infect Dis1995;27:241-243.
11.
McGhee B., Jarjour IT: Single-dose intravenous immune globulin treatment of Guillain-Barré syndrome. Am J Hosp Pharm1994;51:97-99.
12.
Newberger JW , Takahashi M., Beiser AS, et al: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome . N Engl J Med1991;324:1633-1639.
13.
Brannagan TH , Nagle KJ, Lange DJ, Rowland LP: Complications of intravenous immune globulin treatment in neurologic disease. Neurology1996;47:674-677.